Trial Profile
Effectiveness of Daclatasvir-Containing Regimens in Patients Treated in Real-Life Setting in Kingdom of Saudi Arabia (KSA), United Arab Emirates (UAE) and Qatar
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 10 Oct 2017 Status changed from active, no longer recruiting to completed.
- 04 Jul 2017 New trial record